The Florida Melanoma Trial I: A Prospective Multicenter Phase I/II Trial of Postoperative Hypofractionated Adjuvant Radiotherapy with Concurrent Interferon-Alfa-2b in the Treatment of Advanced Stage III Melanoma with Long-Term Toxicity Follow-Up

Table 4

Number of patients experiencing high-grade (Gr 3-4) late toxicity (𝑛=11).

Toxicity	Gr 3	Gr 4
Skin	0	1*
Subcutaneous fibrosis	0	0
Joint	0	0
Lymphedema	0	0
Brachial plexopathy	0	1*

*One patient same arm.